VGZ vs. ESPR
VGZ (Vista Gold Corp.) and ESPR (Esperion Therapeutics, Inc.) are both stocks. VGZ operates in Gold (Basic Materials), while ESPR operates in Biotechnology (Healthcare). Over the past 10 years, VGZ returned 7.84%/yr vs -14.95%/yr for ESPR. At a 0.04 correlation, their price movements are largely independent.
Performance
VGZ vs. ESPR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, VGZ achieves a 18.78% return, which is significantly higher than ESPR's -14.86% return. Over the past 10 years, VGZ has outperformed ESPR with an annualized return of 7.84%, while ESPR has yielded a comparatively lower -14.95% annualized return.
VGZ
- 1D
- 6.36%
- 1M
- 1.30%
- YTD
- 18.78%
- 6M
- -0.85%
- 1Y
- 134.16%
- 3Y*
- 63.73%
- 5Y*
- 14.48%
- 10Y*
- 7.84%
ESPR
- 1D
- 0.00%
- 1M
- 0.96%
- YTD
- -14.86%
- 6M
- -18.18%
- 1Y
- 162.50%
- 3Y*
- 35.36%
- 5Y*
- -34.62%
- 10Y*
- -14.95%
VGZ vs. ESPR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
VGZ Vista Gold Corp. | 18.78% | 253.05% | 23.48% | -8.73% | -30.22% | -34.31% | 48.97% | 38.10% | -25.00% | -26.77% |
ESPR Esperion Therapeutics, Inc. | -14.86% | 68.18% | -26.42% | -52.01% | 24.60% | -80.77% | -56.40% | 29.63% | -30.13% | 425.88% |
Correlation
The correlation between VGZ and ESPR is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.12 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.09 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.09 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.06 |
Correlation (All Time) Calculated using the full available price history since Jun 26, 2013 | 0.04 |
Fundamentals
VGZ:
$307.94M
ESPR:
$791.76M
VGZ:
-$0.06
ESPR:
-$0.03
VGZ:
$0.00
ESPR:
$418.24M
VGZ:
-$66.00K
ESPR:
$226.32M
VGZ:
-$4.85M
ESPR:
$77.18M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VGZ vs. ESPR — Risk / Return Rank
VGZ
ESPR
VGZ vs. ESPR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Vista Gold Corp. (VGZ) and Esperion Therapeutics, Inc. (ESPR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| VGZ | ESPR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.10 | ||
| Sortino ratioReturn per unit of downside risk | -0.53 | ||
| Omega ratioGain probability vs. loss probability | 1.29 | 1.36 | -0.07 |
| Calmar ratioReturn relative to maximum drawdown | 3.19 | 3.07 | +0.12 |
| Martin ratioReturn relative to average drawdown | 6.86 | 7.68 | -0.83 |
Loading charts...
Drawdowns
VGZ vs. ESPR - Drawdown Comparison
The maximum VGZ drawdown since its inception was -99.06%, roughly equal to the maximum ESPR drawdown of -99.37%. Use the drawdown chart below to compare losses from any high point for VGZ and ESPR.
Loading charts...
Drawdown Indicators
| VGZ | ESPR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.06% | -99.37% | +0.31% |
Max Drawdown (1Y)Largest decline over 1 year | -42.30% | -53.19% | +10.89% |
Max Drawdown (3Y)Largest decline over 3 years | -46.23% | -80.94% | +34.71% |
Max Drawdown (5Y)Largest decline over 5 years | -78.19% | -97.16% | +18.97% |
Max Drawdown (10Y)Largest decline over 10 years | -85.10% | -99.10% | +14.00% |
Current DrawdownCurrent decline from peak | -82.31% | -97.27% | +14.96% |
Average DrawdownAverage peak-to-trough decline | -70.36% | -69.99% | -0.37% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 19.65% | 21.30% | -1.65% |
Volatility
VGZ vs. ESPR - Volatility Comparison
Vista Gold Corp. (VGZ) has a higher volatility of 16.84% compared to Esperion Therapeutics, Inc. (ESPR) at 1.06%. This indicates that VGZ's price experiences larger fluctuations and is considered to be riskier than ESPR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| VGZ | ESPR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.84% | 1.06% | +15.78% |
Volatility (6M)Calculated over the trailing 6-month period | 64.35% | 61.44% | +2.91% |
Volatility (1Y)Calculated over the trailing 1-year period | 81.23% | 92.66% | -11.43% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 65.80% | 91.79% | -25.99% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 66.60% | 84.61% | -18.01% |
Dividends
VGZ vs. ESPR - Dividend Comparison
Neither VGZ nor ESPR has paid dividends to shareholders.
Financials
VGZ vs. ESPR - Financials Comparison
This section allows you to compare key financial metrics between Vista Gold Corp. and Esperion Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
VGZ and ESPR have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
VGZ has higher volatility (16.84%) compared to ESPR (1.06%). In terms of maximum drawdown, VGZ dropped -99.06% vs ESPR's -99.37%.
ESPR currently has the higher Sharpe Ratio (1.76 vs 1.66), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for VGZ and ESPR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer